INTERNATIONAL: Drugs firms reach US$260 million opioid settlement

Four drugs companies have reached a $260m (£200m) deal with two Ohio counties over their role in fuelling the US opioid crisis.

The agreement averts a trial that had been scheduled to start in Ohio.

The counties had been seeking billions from Israel-based drugmaker Teva and drug distributors AmerisourceBergen, Cardinal Health and McKesson.

A trial for Walgreens Boots Alliance, which had also been accused, will be rescheduled.

The last-minute deal was announced on Monday by the judge overseeing the trial in Cleveland.